Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BDi Biotechnology is a specialized contract development and manufacturing organization (CDMO) focused on the development and scale-up of biotechnological processes. Based in Spain, the company provides end-to-end services ranging from strain engineering and process optimization to pilot-scale production and industrial technology transfer. BDi Biotechnology serves diverse sectors including pharmaceuticals, food and feed, and industrial biotechnology, with a particular emphasis on fermentation-based production. The company's expertise lies in bridging the gap between laboratory-scale research and large-scale commercial manufacturing. In 2022, BDi Biotechnology was acquired by the French group Abeo to strengthen its position in the global bio-based solutions market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BDi Biotechnology.